LONDON BROKER RATINGS: Bernstein reinitiates Convatec at 'outperform'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 68.00p on 23-02-2026 at 19:40:07 |
|---|---|
| Change | -0.10p -0.15% |
| Buy | 68.35p |
| Sell | 68.00p |
| Last Trade: | Sell 7,000.00 at 68.656p |
| Day's Volume: | 758,241 |
| Last Close: | 68.00p |
| Open: | 67.65p |
| ISIN: | GB00BL6NGV24 |
| Day's Range | 67.00p - 69.35p |
| 52wk Range: | 43.94p - 100.80p |
| Market Capitalisation: | £657.28m |
| VWAP: | 68.28944p |
| Shares in Issue: | 966.58m |
Dr. Martens (DOCS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 7,000 | 68.656p | SI Trade Suspected SELL Trade |
16:47:09 - 23-Feb-26 |
| Buy* | 125,000 | 68.43p | Ordinary |
16:36:19 - 23-Feb-26 |
| Buy* | 331,669 | 68.00p | Suspected BUY Trade |
16:35:22 - 23-Feb-26 |
| Buy* | 260 | 68.15p | Automatic Execution |
16:29:40 - 23-Feb-26 |
| Buy* | 1 | 68.15p | Automatic Execution |
16:29:40 - 23-Feb-26 |
| Buy* | 1,089 | 68.15p | Automatic Execution |
16:29:40 - 23-Feb-26 |
| Buy* | 949 | 68.15p | Automatic Execution |
16:29:40 - 23-Feb-26 |
| Buy* | 823 | 68.15p | Automatic Execution |
16:29:40 - 23-Feb-26 |
| Buy* | 221 | 68.10p | Automatic Execution |
16:28:30 - 23-Feb-26 |
| Buy* | 584 | 68.10p | Automatic Execution |
16:28:30 - 23-Feb-26 |
Dr. Martens (DOCS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Feb 2026 10:49 am | RNS | Director/PDMR Shareholding |
| 30th Jan 2026 11:15 am | RNS | Total Voting Rights |
| 29th Jan 2026 7:00 am | RNS | EBT Share Purchase |
| 27th Jan 2026 7:00 am | RNS | Holding(s) in Company |
| 27th Jan 2026 7:00 am | RNS | Q3 FY26 Trading Statement |
| 15th Jan 2026 9:24 am | RNS | Director/PDMR Shareholding |
| 31st Dec 2025 11:11 am | RNS | Total Voting Rights |
| 31st Dec 2025 11:11 am | RNS | Total Voting Rights |
| 12th Dec 2025 3:00 pm | RNS | Director/PDMR Shareholding |
| 12th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |